Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.
Crossref DOI link: https://doi.org/10.1007/s12032-021-01528-4
Published Online: 2021-06-11
Published Print: 2021-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Onal, Cem http://orcid.org/0000-0002-2742-9021
Oymak, Ezgi
Guler, Ozan Cem
Text and Data Mining valid from 2021-06-11
Version of Record valid from 2021-06-11
Article History
Received: 25 May 2021
Accepted: 4 June 2021
First Online: 11 June 2021
Declarations
:
: All authors declare no conflicts of interest related to this article.